These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 29411170)
21. Direct Reprogramming of Human DMD Fibroblasts into Myotubes for In Vitro Evaluation of Antisense-Mediated Exon Skipping and Exons 45-55 Skipping Accompanied by Rescue of Dystrophin Expression. Lee JJA; Saito T; Duddy W; Takeda S; Yokota T Methods Mol Biol; 2018; 1828():141-150. PubMed ID: 30171539 [TBL] [Abstract][Full Text] [Related]
22. Molecular correction of Duchenne muscular dystrophy by splice modulation and gene editing. Hanson B; Wood MJA; Roberts TC RNA Biol; 2021 Jul; 18(7):1048-1062. PubMed ID: 33472516 [TBL] [Abstract][Full Text] [Related]
23. Overview of gene therapy in spinal muscular atrophy and Duchenne muscular dystrophy. Abreu NJ; Waldrop MA Pediatr Pulmonol; 2021 Apr; 56(4):710-720. PubMed ID: 32886442 [TBL] [Abstract][Full Text] [Related]
30. Antisense Oligonucleotide Treatment in a Humanized Mouse Model of Duchenne Muscular Dystrophy and Highly Sensitive Detection of Dystrophin Using Western Blotting. Maruyama R; Yokota T Methods Mol Biol; 2021; 2224():203-214. PubMed ID: 33606217 [TBL] [Abstract][Full Text] [Related]
31. Dystrophin expression in the mdx mouse after localised and systemic administration of a morpholino antisense oligonucleotide. Fletcher S; Honeyman K; Fall AM; Harding PL; Johnsen RD; Wilton SD J Gene Med; 2006 Feb; 8(2):207-16. PubMed ID: 16285002 [TBL] [Abstract][Full Text] [Related]
32. Nusinersen in the Treatment of Spinal Muscular Atrophy. Goodkey K; Aslesh T; Maruyama R; Yokota T Methods Mol Biol; 2018; 1828():69-76. PubMed ID: 30171535 [TBL] [Abstract][Full Text] [Related]
33. Making sense of antisense oligonucleotides: A narrative review. Goyal N; Narayanaswami P Muscle Nerve; 2018 Mar; 57(3):356-370. PubMed ID: 29105153 [TBL] [Abstract][Full Text] [Related]
38. FDA Approval of Nusinersen for Spinal Muscular Atrophy Makes 2016 the Year of Splice Modulating Oligonucleotides. Aartsma-Rus A Nucleic Acid Ther; 2017 Apr; 27(2):67-69. PubMed ID: 28346110 [No Abstract] [Full Text] [Related]
39. Combined treatment with the histone deacetylase inhibitor LBH589 and a splice-switch antisense oligonucleotide enhances SMN2 splicing and SMN expression in Spinal Muscular Atrophy cells. Pagliarini V; Guerra M; Di Rosa V; Compagnucci C; Sette C J Neurochem; 2020 Apr; 153(2):264-275. PubMed ID: 31811660 [TBL] [Abstract][Full Text] [Related]
40. Antisense Oligonucleotide Induction of the hnRNPA1b Isoform Affects Pre-mRNA Splicing of Toosaranont J; Ruschadaariyachat S; Mujchariyakul W; Arora JK; Charoensawan V; Suktitipat B; Palmer TN; Fletcher S; Wilton SD; Mitrpant C Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409296 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]